D41.20

Neoplasm of uncertain behavior of unspecified ureter

FY2027Chapter 2: Neoplasms/D37–D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes

BillableComplete code, valid to report

D41.20 (also written D4120) is a billable ICD-10-CM diagnosis code for neoplasm of uncertain behavior of unspecified ureter. It is part of the FY2027 code set, effective October 1, 2026. It is one of the 13 codes in category D41 (Neoplasm of uncertain behavior of urinary organs). Its coding notes include 1 Excludes1 entry.

Excludes1

Not coded here. The listed conditions generally should not be reported together.

Also from chapter/block level (1 note)
Inherited from D37–D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
  • neoplasms of unspecified behavior (D49.-)

Care settings

How CMS programs treat this code. These are CMS claim edits and list entries, not coverage or eligibility rules.

IPF Comorbidity

On the CMS IPF comorbidity list.

Comorbidity categoryFactor
Oncology Treatment1.44
It counts as a comorbidity when reported as a secondary diagnosis and actively treated during the stay. An IPF receives only one adjustment within a category and can receive adjustments in more than one category.

Source: CMS IPF PPS FY 2027 final rule (CMS-1847-F), Addendum B-3 (comorbidity codes with adjustment factor); effective for discharges on or after October 1, 2026

Notes

Also from chapter/block level (9 notes)
Inherited from D37–D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
  • Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
Inherited from Chapter 2 Neoplasms
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).